Global Restless Legs Syndrome Market 2015-2019

www.technavio.comenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Global Restless Legs Syndrome Market 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Buying Criteria

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on theGlobal Restless Legs Syndrome

Market 2015-2019,please mail us at

enquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “The increase in preference for the use of off-label drugs is one of the major trends in the market. Since the exact etiology of the disease is unknown, generics of different classes are used to relieve the symptoms. Another major trend is the entry of drugs with novel mechanisms of action. Drugs such as safinamide, which have an unknown mechanism of action, appear to reduce the symptoms associated with RLS.”

• RLS is a neurological disease; it is also known as Willis-Ekbom disease. People with RLS experience an overwhelming desire to move their legs. It leads to an unpleasant pain in the limbs, leading to a disturbance in sleep pattern of patients. The condition aggravates at night or when the person is at rest. It occurs in both genders, but higher prevalence is seen in women than men.

• Technavio's analysts forecast the global RLS market to grow at a CAGR of 11.46% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Global Restless Legs Syndrome Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and

for a full list of vendors view our

report:

Global Restless Legs Syndrome Market 2015-2019

Boehringer Ingelheim

GlaxoSmithKline

UCB

Boehringer Ingelheim was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. Boehringer Ingelheim is a research driven biopharmaceutical company that focuses on R&D, manufacturing, and marketing of a wide range of pharmaceuticals, biomolecules, and chemicals in Germany and internationally.

GlaxoSmithKline was incorporated in 1999 as a result of the merger between Glaxo Wellcome and SmithKline Beecham. The company is headquartered in Brentford, Middlesex, UK. It develops, manufactures, and markets pharmaceutical products worldwide.

UCB was incorporated in 1928, and is headquartered in Brussels, Belgium. It is a global pharmaceutical company which engages in the R&D, manufacturing, and marketing of drugs and pharmaceuticals for the treatment of CNS disorders and immunological disorders.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The global restless legs syndrome market is expected to grow at a rapid pace during the forecast period, driven by high unmet medical needs and the increase in the patient population.

• In addition, the availability of numerous patient assistance programs and the increase in awareness about the disease will drive the market growth.

• However, the unknown disease etiology, misdiagnosis of the condition, and few drugs under development will hinder the market growth.

• The global restless legs syndrome market is dominated by Boehringer Ingelheim, GlaxoSmithKline, UCB, and XenoPort.

USA – CANADA – UK – CHINA – INDIA

Key Buying CriteriaGuest Bloggers

• Authenticity • Delivery • Price• Service

Support

Parameter Details

Availability Drugs used in the treatment of RLS should be readily available.

Efficacy Drugs used in the treatment of RLS should be efficient and show positive results.

Affordability

Drugs used in the treatment of RLS should be affordable for all income groups.

Safety Drugs used in the treatment of RLS should be safe and have minimal adverse effects.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Global Restless Legs Syndrome Market 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

media@technavio.com

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION